Sectors

Taiho Ventures returned for a $72m series B round closed by Werewolf Therapeutics, which is now set to advance two lead oncology assets through phase 1 trials.

Bristol Myers Squibb, Eli Lilly and Novo are among the limited partners in the pharmaceutical-focused venture firm's BGV IV fund, which has reached its final close.

UPMC Enterprise has returned for a $72m series B round raised by Werewolf Therapeutics, which is now set to advance two lead assets through phase 1 trials.

Osage University Partners has contributed to an $80m round for Dice Molecules, which is advancing Stanford University research and is also backed by Sanofi and Alexandria.

Novo helped the cardiac pump developer CorWave secure series C funding to increase its total funding to over $95m.

Diane Roujou de Boubée had previously held a manager position at corporate venture capital vehicle Sodexo Ventures.

The newly launched cancer therapy startup plans to initiate clinical trials this year after securing funding from Alexandria Real Estate Equities’ venture arm.

Steve Mitzenmacher spent nine years in corporate development and strategy at NetApp before joining Rackspace earlier this month.

Business-to-business (B2B) e-commerce marketplace Udaan extended its series D round with a $280m tranche, featuring Tencent. The company is one of the comparatively few B2B e-commerce deals we have reported, despite the relative size and importance of the B2B in it.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

MUI formed Pan Malaysia Ventures (PMV) last year and has invested up to $200,000 each in six startups.